Cytek Biosciences (CTKB) Income from Continuing Operations (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Income from Continuing Operations came in at 18873000.0 in Q1 2026, down 65.52% YoY from 54741782.24 in Q1 2025, and up 57.14% on a QoQ basis from 44029000.0 in Q4 2025.
Cytek Biosciences (CTKB) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Income from Continuing Operations data on file, last reported at 18873000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 65.52% year-over-year to 18873000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 73954000.0 (down 555.85% YoY) and the FY2025 annual result came in at 66539000.0, down 1005.3% from the prior year.
- Income from Continuing Operations rose to 18873000.0 in Q1 2026, from 44029000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 9603000.0 in Q4 2024 to a low of 44029000.0 in Q4 2025.
- A 5-year average of 5948647.06 and a median of 5469000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 419.14% in 2022, down 2215.69% in 2022.
- Tracing CTKB's Income from Continuing Operations over 5 years: stood at 3718000.0 in 2022, then surged by 48.01% to 5503000.0 in 2023, then jumped by 74.5% to 9603000.0 in 2024, then slumped by 558.49% to 44029000.0 in 2025, then soared by 57.14% to 18873000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 18873000.0 (Q1 2026), 44029000.0 (Q4 2025), and 5469000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Cytek Biosciences | 605.23 Mn | 531.38 Mn | 28.34 Mn | -12.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.16 Mn |
| Mar 31, 2026 | -18.87 Mn |
| Dec 31, 2025 | -44.03 Mn |
| Sep 30, 2025 | -5.47 Mn |
| Jun 30, 2025 | -5.58 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 957,000.00 |
| Jun 30, 2024 | -10.43 Mn |
| Mar 31, 2024 | -6.19 Mn |
| Dec 31, 2023 | 5.50 Mn |
| Sep 30, 2023 | -6.46 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -6.84 Mn |
| Dec 31, 2022 | 3.72 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | -702,000.00 |
| Mar 31, 2022 | -2.16 Mn |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | 1.42 Mn |